Evidence map›Paper›PMID 40127205›Full record

ArticleDrug development research2025

Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid.

Marisa Cabeza, Karla Mejía, Fernando García, Ivonne Heuze, Miguel Morales, Mauricio Rodríguez-Dorantes

Abstract read
In one paragraph

Article in Drug development research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marisa CabezaDepartamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.ORCID 0000-0002-5096-8840
Karla MejíaDepartamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.
Fernando GarcíaDepartamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.
Ivonne HeuzeDepartamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.
Miguel MoralesLaboratorio de Oncogenómica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Mauricio Rodríguez-DorantesLaboratorio de Oncogenómica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.

Funding

This study was conducted with funds approved by the Universidad Autónoma Metropolitana-Xochimilco.
6 · The paper itself

Abstract

Studies suggest that vegetarians and Asians have lower mortality rates from prostate cancer compared to men who follow a Western diet. β-sitosterol, a key compound of plant-based diets, has been found to induce significant changes in the ultrasonic structure of the prostatic adenomas, making it a promising candidate for further prostate cancer research. Consequently, we investigated the potential of β-sitosterol and the synthetic derivative 2 as potent inhibitors of androgen synthesis, a critical process for the growth and survival of prostate tumor LNCaP cells. Solubilized LNCaP microsomes were used as a source of SRD5A1 and AKR1C3 to monitor androgen synthesis from labeled androstenedione, both in the presence and absence of β-sitosterol or 2. Furthermore, the effect of these steroids on LNCaP viability was determined using the MTT method. Our findings revealed significant insights into the androgen synthesis pathways in LNCaP cells. The most efficient metabolic route for dihydrotestosterone formation was the conversion of androstenedione to 5α-androstanedione rather than from testosterone in LNCaP. This conclusion is supported by the Vmax values for 5α-androstanedione formation (271.05 ± 5.0 ng/mg protein/min) and the Vmax of testosterone formation (80.1 ± 8.0 ng/mg protein/min). Both β-sitosterol and 2 demonstrated substantial inhibitory effects of these enzymes for dihydrotestosterone formation and significantly reduced cell viability, highlighting their therapeutic potential. These findings enhance our understanding of the inhibitory effects of β-sitosterol and 2 on LNCaP cells and suggest their promising application in the treatment of prostate cancer.

Indexed as

AndrogensProstatic NeoplasmsSitosterols3-Oxo-5-alpha-Steroid 4-DehydrogenaseAldo-Keto Reductase Family 1 Member C3AndrostenedioneCell Line, TumorCell SurvivalHumansMaleMembrane ProteinsMicrosomes3-Oxo-5-alpha-Steroid 4-DehydrogenaseAKR1C3 protein, humanAldo-Keto Reductase Family 1 Member C3AndrogensAndrostenedionegamma-sitosterolMembrane ProteinsSitosterolsSRD5A1 protein, human17β‐hydroxysteroid dehydrogenase activityandrostane derivativeLNCaP cells proliferationtype 1 5α‐reductase activityβ‐sitosterol

Identifiers

PMID40127205
PMCPMC11932574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.